MiR-215 modulates gastric cancer cell proliferation by targeting RB1

Cancer Letters

Volumn 342, Issue 1, 2014, Pages 27-35

  Deng, Yujie ^a   Huang, Zhenxia ^a,b   Xu, Yanjun ^a   Jin, Juan ^a   Zhuo, Wei ^a,b   Zhang, Cheng ^a   Zhang, Xuting ^a   Shen, Minhong ^a   Yan, Xiaoyi ^a   Wang, Liangjing ^a   Wang, Xiaojia ^c   Kang, Yibin ^d   Si, Jianmin ^a,b   Zhou, Tianhua ^a,b  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b ZHEJIANG UNIVERSITY   (China)

^c ZHEJIANG CANCER HOSPITAL   (China)

^d PRINCETON UNIVERSITY   (United States)

Author keywords

Gastric cancer; MiR 215; Proliferation; Retinoblastoma

Indexed keywords

MICRORNA; MICRORNA 215; TUMOR MARKER; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ADULT; AREA UNDER THE CURVE; ARTICLE; CANCER CELL; CELL COUNT; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE PROGRESSION; CELL PROLIFERATION; CELL SURVIVAL; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE MARKER; DOWN REGULATION; FEMALE; G1 PHASE CELL CYCLE CHECKPOINT; GENE EXPRESSION; GENE FUNCTION; GENE SILENCING; GENE TARGETING; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PRIORITY JOURNAL; RB1 GENE; RECEIVER OPERATING CHARACTERISTIC; S PHASE CELL CYCLE CHECKPOINT; SENSITIVITY AND SPECIFICITY; STOMACH CANCER; TUMOR SUPPRESSOR GENE; UPREGULATION;

GASTRIC CANCER; MIR-215; PROLIFERATION; RETINOBLASTOMA;

3' UNTRANSLATED REGIONS; AGED; AREA UNDER CURVE; BASE SEQUENCE; BINDING SITES; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MICRORNAS; RETINOBLASTOMA PROTEIN; RNA INTERFERENCE; ROC CURVE; STOMACH NEOPLASMS; TRANSCRIPTOME; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 84887608317     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2013.08.033     Document Type: Article

References (58)

1. Jemal A., Bray F., Center M.M., Ferlay J., Ward E., Forman D. Global cancer statistics. CA Cancer J. Clin. 2011, 61:69-90.
2. Ambros V. The functions of animal microRNAs. Nature 2004, 431:350-355.
3. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116:281-297.
4. Pasquinelli A.E., Hunter S., Bracht J. MicroRNAs: a developing story. Curr. Opin. Genet. Dev. 2005, 15:200-205.
5. Orom U.A., Nielsen F.C., Lund A.H. MicroRNA-10a binds the 5'UTR of ribosomal protein mRNAs and enhances their translation. Mol. Cell 2008, 30:460-471.
6. Tsai N.P., Lin Y.L., Wei L.N. MicroRNA mir-346 targets the 5'-untranslated region of receptor-interacting protein 140 (RIP140) mRNA and up-regulates its protein expression. Biochem. J. 2009, 424:411-418.
7. Moretti F., Thermann R., Hentze M.W. Mechanism of translational regulation by miR-2 from sites in the 5' untranslated region or the open reading frame. RNA 2010, 16:2493-2502.
8. Kozomara A., Griffiths-Jones S. MiRBase: integrating microRNA annotation and deep-sequencing data. Nucleic Acids Res. 2011, 39:D152-D157.
9. Du Y., Xu Y., Ding L., Yao H., Yu H., Zhou T., Si J. Down-regulation of miR-141 in gastric cancer and its involvement in cell growth. J. Gastroenterol. 2009, 44:556-561.
10. Ding L., Xu Y., Zhang W., Deng Y., Si M., Du Y., Yao H., Liu X., Ke Y., Si J., Zhou T. MiR-375 frequently downregulated in gastric cancer inhibits cell proliferation by targeting JAK2. Cell Res. 2010, 20:784-793.
11. Tsukamoto Y., Nakada C., Noguchi T., Tanigawa M., Nguyen L.T., Uchida T., Hijiya N., Matsuura K., Fujioka T., Seto M., Moriyama M. MicroRNA-375 is downregulated in gastric carcinomas and regulates cell survival by targeting PDK1 and 14-3-3zeta. Cancer Res. 2010, 70:2339-2349.
12. Tie J., Pan Y., Zhao L., Wu K., Liu J., Sun S., Guo X., Wang B., Gang Y., Zhang Y., Li Q., Qiao T., Zhao Q., Nie Y., Fan D. MiR-218 inhibits invasion and metastasis of gastric cancer by targeting the Robo1 receptor. PLoS Genet. 2010, 6:e1000879.
13. Wang H.J., Ruan H.J., He X.J., Ma Y.Y., Jiang X.T., Xia Y.J., Ye Z.Y., Tao H.Q. MicroRNA-101 is down-regulated in gastric cancer and involved in cell migration and invasion. Eur. J. Cancer 2010.
14. Feng R., Chen X., Yu Y., Su L., Yu B., Li J., Cai Q., Yan M., Liu B., Zhu Z. MiR-126 functions as a tumour suppressor in human gastric cancer. Cancer Lett. 2010, 298:50-63.
15. Petrocca F., Visone R., Onelli M.R., Shah M.H., Nicoloso M.S., de Martino I., Iliopoulos D., Pilozzi E., Liu C.G., Negrini M., Cavazzini L., Volinia S., Alder H., Ruco L.P., Baldassarre G., Croce C.M., Vecchione A. E2F1-regulated microRNAs impair TGFbeta-dependent cell-cycle arrest and apoptosis in gastric cancer. Cancer Cell 2008, 13:272-286.
16. Zhang Z., Li Z., Gao C., Chen P., Chen J., Liu W., Xiao S., Lu H. MiR-21 plays a pivotal role in gastric cancer pathogenesis and progression. Lab Invest. 2008, 88:1358-1366.
17. Chun-Zhi Z., Lei H., An-Ling Z., Yan-Chao F., Xiao Y., Guang-Xiu W., Zhi-Fan J., Pei-Yu P., Qing-Yu Z., Chun-Sheng K. MicroRNA-221 and microRNA-222 regulate gastric carcinoma cell proliferation and radioresistance by targeting PTEN. BMC Cancer 2010, 10:367.
18. Feng L., Xie Y., Zhang H., Wu Y. MiR-107 targets cyclin-dependent kinase 6 expression, induces cell cycle G1 arrest and inhibits invasion in gastric cancer cells. Med. Oncol. 2012, 29:856-863.
19. Li X., Zhang Y., Shi Y., Dong G., Liang J., Han Y., Wang X., Zhao Q., Ding J., Wu K., Fan D. MicroRNA-107, an oncogene microRNA that regulates tumour invasion and metastasis by targeting DICER1 in gastric cancer. J. Cell. Mol. Med. 2011, 15:1887-1895.
20. Song G., Zeng H., Li J., Xiao L., He Y., Tang Y., Li Y. MiR-199a regulates the tumor suppressor mitogen-activated protein kinase kinase kinase 11 in gastric cancer. Biol. Pharm. Bull. 2010, 33:1822-1827.
21. Jiang Z., Guo J., Xiao B., Miao Y., Huang R., Li D., Zhang Y. Increased expression of miR-421 in human gastric carcinoma and its clinical association. J. Gastroenterol. 2010, 45:17-23.
22. DeGregori J., Johnson D.G. Distinct and overlapping roles for E2F family members in transcription, proliferation and apoptosis. Curr. Mol. Med. 2006, 6:739-748.
23. Chen H.Z., Tsai S.Y., Leone G. Emerging roles of E2Fs in cancer: an exit from cell cycle control. Nat. Rev. Cancer 2009, 9:785-797.
24. Friend S.H., Bernards R., Rogelj S., Weinberg R.A., Rapaport J.M., Albert D.M., Dryja T.P. A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature 1986, 323:643-646.
25. Deshpande A., Hinds P.W. The retinoblastoma protein in osteoblast differentiation and osteosarcoma. Curr. Mol. Med. 2006, 6:809-817.
26. Doorbar J. Molecular biology of human papillomavirus infection and cervical cancer. Clin. Sci. (Lond.) 2006, 110:525-541.
27. Perez-Ordonez B., Beauchemin M., Jordan R.C. Molecular biology of squamous cell carcinoma of the head and neck. J. Clin. Pathol. 2006, 59:445-453.
28. Munakata T., Liang Y., Kim S., McGivern D.R., Huibregtse J., Nomoto A., Lemon S.M. Hepatitis C virus induces E6AP-dependent degradation of the retinoblastoma protein. PLoS Pathog. 2007, 3:1335-1347.
29. Meuwissen R., Linn S.C., Linnoila R.I., Zevenhoven J., Mooi W.J., Berns A. Induction of small cell lung cancer by somatic inactivation of both Trp53 and Rb1 in a conditional mouse model. Cancer Cell 2003, 4:181-189.
30. Cito L., Pentimalli F., Forte I., Mattioli E., Giordano A. Rb family proteins in gastric cancer (review). Oncol. Rep. 2010, 24:1411-1418.
31. Ogawa M., Maeda K., Chung Y.S., Onoda N., Kato Y., Nakata B., Sowa M. Correlation between expression of RB protein and prognosis of gastric cancer. Gan To Kagaku Ryoho 1996, 23(Suppl 2):148-150.
32. He X.S., Rong Y.H., Su Q., Luo Q., He D.M., Li Y.L., Chen Y. Expression of p16 gene and Rb protein in gastric carcinoma and their clinicopathological significance. World J. Gastroenterol. 2005, 11:2218-2223.
33. Yang X., Feng M., Jiang X., Wu Z., Li Z., Aau M., Yu Q. MiR-449a and miR-449b are direct transcriptional targets of E2F1 and negatively regulate pRb-E2F1 activity through a feedback loop by targeting CDK6 and CDC25A. Genes Dev. 2009, 23:2388-2393.
34. Noonan E.J., Place R.F., Basak S., Pookot D., Li L.C. MiR-449a causes Rb-dependent cell cycle arrest and senescence in prostate cancer cells. Oncotarget 2010, 1:349-358.
35. Lu Y., Thomson J.M., Wong H.Y., Hammond S.M., Hogan B.L. Transgenic over-expression of the microRNA miR-17-92 cluster promotes proliferation and inhibits differentiation of lung epithelial progenitor cells. Dev. Biol. 2007, 310:442-453.
36. Bohlig L., Friedrich M., Engeland K. P53 activates the PANK1/miRNA-107 gene leading to downregulation of CDK6 and p130 cell cycle proteins. Nucleic Acids Res. 2011, 39:440-453.
37. Tsang W.P., Ng E.K., Ng S.S., Jin H., Yu J., Sung J.J., Kwok T.T. Oncofetal H19-derived miR-675 regulates tumor suppressor RB in human colorectal cancer. Carcinogenesis 2010, 31:350-358.
38. Scarola M., Schoeftner S., Schneider C., Benetti R. MiR-335 directly targets Rb1 (pRb/p105) in a proximal connection to p53-dependent stress response. Cancer Res. 2010, 70:6925-6933.
39. Yang Y., Yan X., Cai Y., Lu Y., Si J., Zhou T. NudC-like protein 2 regulates the LIS1/dynein pathway by stabilizing LIS1 with Hsp90. Proc. Natl. Acad. Sci. USA 2010, 107:3499-3504.
40. Ueda T., Volinia S., Okumura H., Shimizu M., Taccioli C., Rossi S., Alder H., Liu C.G., Oue N., Yasui W., Yoshida K., Sasaki H., Nomura S., Seto Y., Kaminishi M., Calin G.A., Croce C.M. Relation between microRNA expression and progression and prognosis of gastric cancer: a microRNA expression analysis. Lancet Oncol. 2010, 11:136-146.
41. Lewis B.P., Shih I.H., Jones-Rhoades M.W., Bartel D.P., Burge C.B. Prediction of mammalian microRNA targets. Cell 2003, 115:787-798.
42. Krek A., Grun D., Poy M.N., Wolf R., Rosenberg L., Epstein E.J., MacMenamin P., da Piedade I., Gunsalus K.C., Stoffel M., Rajewsky N. Combinatorial microRNA target predictions. Nat. Genet. 2005, 37:495-500.
43. Betel D., Wilson M., Gabow A., Marks D.S., Sander C. The microRNA.org resource: targets and expression. Nucleic Acids Res. 2008, 36:D149-D153.
44. Goodrich D.W., Wang N.P., Qian Y.W., Lee E.Y., Lee W.H. The retinoblastoma gene product regulates progression through the G1 phase of the cell cycle. Cell 1991, 67:293-302.
45. Nevins J.R. E2F: a link between the Rb tumor suppressor protein and viral oncoproteins. Science 1992, 258:424-429.
46. Georges S.A., Biery M.C., Kim S.Y., Schelter J.M., Guo J., Chang A.N., Jackson A.L., Carleton M.O., Linsley P.S., Cleary M.A., Chau B.N. Coordinated regulation of cell cycle transcripts by p53-Inducible microRNAs, miR-192 and miR-215. Cancer Res. 2008, 68:10105-10112.
47. Braun C.J., Zhang X., Savelyeva I., Wolff S., Moll U.M., Schepeler T., Orntoft T.F., Andersen C.L., Dobbelstein M. P53-Responsive micrornas 192 and 215 are capable of inducing cell cycle arrest. Cancer Res. 2008, 68:10094-10104.
48. Pichiorri F., Suh S.S., Rocci A., De Luca L., Taccioli C., Santhanam R., Zhou W., Benson D.M., Hofmainster C., Alder H., Garofalo M., Di Leva G., Volinia S., Lin H.J., Perrotti D., Kuehl M., Aqeilan R.I., Palumbo A., Croce C.M. Downregulation of p53-inducible microRNAs 192, 194, and 215 impairs the p53/MDM2 autoregulatory loop in multiple myeloma development. Cancer Cell 2010, 18:367-381.
49. Song B., Wang Y., Titmus M.A., Botchkina G., Formentini A., Kornmann M., Ju J. Molecular mechanism of chemoresistance by miR-215 in osteosarcoma and colon cancer cells. Mol. Cancer 2010, 9:96.
50. Boni V., Bitarte N., Cristobal I., Zarate R., Rodriguez J., Maiello E., Garcia-Foncillas J., Bandres E. MiR-192/miR-215 influence 5-fluorouracil resistance through cell cycle-mediated mechanisms complementary to its post-transcriptional thymidilate synthase regulation. Mol. Cancer Ther. 2010, 9:2265-2275.
51. Wijnhoven B.P., Hussey D.J., Watson D.I., Tsykin A., Smith C.M., Michael M.Z. MicroRNA profiling of Barrett's oesophagus and oesophageal adenocarcinoma. Br. J. Surg. 2010, 97:853-861.
52. Karaayvaz M., Pal T., Song B., Zhang C., Georgakopoulos P., Mehmood S., Burke S., Shroyer K., Ju J. Prognostic significance of miR-215 in colon cancer. Clin. Colorectal Cancer 2011 Dec, 10(4):340-347.
53. Faltejskova P., Svoboda M., Srutova K., Mlcochova J., Besse A., Nekvindova J., Radova L., Fabian P., Slaba K., Kiss I., Vyzula R., Slaby O. Identification and functional screening of microRNAs highly deregulated in colorectal cancer. J. Cell Mol. Med. 2012 Nov, 16(11):2655-2666. 10.1111/j.1582-4934.2012.01579.x.
54. Senanayake U., Das S., Vesely P., Alzoughbi W., Fröhlich L.F., Chowdhury P., Leuschner I., Hoefler G., Guertl B. MiR-192, miR-194, miR-215, miR-200c and miR-141 are downregulated and their common target ACVR2B is strongly expressed in renal childhood neoplasms. Carcinogenesis 2012 May, 33(5):1014-1021. (Epub 2012 Mar 19). 10.1093/carcin/bgs126.
55. Chiang Y., Zhou X., Wang Z., Song Y., Liu Z., Zhao F., Zhu J., Xu H. Expression levels of microRNA-192 and -215 in gastric carcinoma. Pathol. Oncol. Res. 2012 Jul, 18(3):585-591. (Epub 2011 Dec 29). 10.1007/s12253-011-9480-x.
56. Jin Z., Selaru F.M., Cheng Y., Kan T., Agarwal R., Mori Y., Olaru A.V., Yang J., David S., Hamilton J.P., Abraham J.M., Harmon J., Duncan M., Montgomery E.A., Meltzer S.J. MicroRNA-192 and -215 are upregulated in human gastric cancer in vivo and suppress ALCAM expression in vitro. Oncogene 2011, 30:1577-1585.
57. Ziebold U., Reza T., Caron A., Lees J.A. E2F3 contributes both to the inappropriate proliferation and to the apoptosis arising in Rb mutant embryos. Genes Dev. 2001, 15:386-391.
58. Chong J.L., Tsai S.Y., Sharma N., Opavsky R., Price R., Wu L., Fernandez S.A., Leone G. E2f3a and E2f3b contribute to the control of cell proliferation and mouse development. Mol. Cell. Biol. 2009, 29:414-424.